Linked research, clinical, and regulatory source pathways.
Company profile
About Autonomize
Autonomize AI is a healthcare intelligence platform company that transforms fragmented healthcare operations into autonomous, intelligent workflows. Founded in 2022 by former Dell Technologies executive Ganesh Padmanabhan and Kris Nair, the company has been recognized as a 2026 Technology Pioneer by the World Economic Forum. The Autonomize Intelligence Platform serves as an AI operating layer for healthcare, combining healthcare-specific AI agents, workflow intelligence, and domain expertise to help organizations reduce administrative burden and improve care coordination. The platform operates across three of the five largest U.S. health enterprises, addressing complex operational challenges in utilization management, care management, claims processing, pharmacy operations, and appeals. Rather than automating existing broken workflows, Autonomize AI fundamentally reimagines how healthcare decisions are made and executed. The platform features a Knowledge Center with over 10 million clinical, regulatory, and coverage concepts, an AI Marketplace with 160+ ready-to-deploy agents and workflows, AI Studio for workflow design, and Command Center for real-time visibility and governance. Autonomize AI serves health systems, payers, and healthcare enterprises, delivering measurable outcomes including 80% faster case review times, 36,000 FTE clinical hours saved per month, 63% reduction in turnaround time, and 98% AI-generated information acceptance by clinicians. The company's approach embeds compliance, auditability, and human oversight directly into the platform architecture, ensuring that AI augments rather than replaces clinical expertise.
Company description Autonomize official website
Primary marketGenerative AI & Healthcare Infrastructure
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Autonomize?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Appeals and grievances
- Care management
- Claims processing
- Payment integrity
- Pharmacy operations
- Prior authorization workflows
- Risk adjustment
Who it serves
- Clinically Integrated Networks
- Health Systems
- Healthcare Enterprises
- Payers
- Physician Groups
Deployment & integration
Deployment information is currently being developed.
Recorded integration context: Claims management systems, EHR systems, FHIR APIs, Legacy healthcare systems.
Geographic context
MarketsUnited States
Company sourceOfficial website
Company milestones
Platform expansion
Named 2026 Technology Pioneer by World Economic Forum (June 2026). Operating across 3 of 5 largest U.S. health enterprises. Platform processes 2.5M cases across all lines of business, 85K+ requests per month at scale.
Partnerships
Recorded partners
- Altais Health Solutions
- Elevance Health
- Lyric AI
- Molina Healthcare
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
No source-backed Company products are currently listed.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
No linked records are currently available.
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
80% faster case review time
General workflow improvement
36,000 FTE clinical hours saved per month
Enterprise-scale deployment
63% reduction in turnaround time
Case processing
98% AI-generated information accepted by clinicians
Clinical validation
55% reduction in review time
Prior authorization
76% auto-intake approval rate
Prior authorization
78% reduction in documentation time
Care management
150K+ care plans generated annually per enterprise
Care management scale
70% cut in prep effort per case
Appeals and grievances
93% accuracy in document extraction
Document processing
50% faster turnaround across case types
Appeals and grievances
98% accuracy in clinical data abstraction
Pharmacy prior authorization
90% auto-approval rate
Pharmacy prior authorization
45% reduction in prior authorization review time
Altais case study
50% boost in clinical team productivity
Altais case study
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Autonomize
Recent articles published on Autonomize's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Generative AI & Healthcare Infrastructure
Companies providing generative AI platforms, large language models (LLMs), foundation models, or broad AI infrastructure specifically designed for healthcare applications. These companies serve multiple clinical use cases across the health system rather than focusing on a single clinical application or disease area.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.